Key Challenges to Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Southeast Asia, the Middle East, and North Africa: An Expert Perspective

dc.contributor.authorGünen H.
dc.contributor.authorAlzaabi A.
dc.contributor.authorBakhatar A.
dc.contributor.authorAl Mutairi S.
dc.contributor.authorManeechotesuwan K.
dc.contributor.authorTan D.
dc.contributor.authorZeitouni M.
dc.contributor.authorAggarwal B.
dc.contributor.authorBerzanskis A.
dc.contributor.authorCintra O.
dc.contributor.correspondenceGünen H.
dc.contributor.otherMahidol University
dc.date.accessioned2024-09-28T18:24:29Z
dc.date.available2024-09-28T18:24:29Z
dc.date.issued2024-01-01
dc.description.abstractIntroduction: Respiratory syncytial virus (RSV) is a common, highly contagious pathogen and a leading cause of serious illness among infants and older adults. While existing scientific evidence has predominantly focused on the epidemiology and disease burden of RSV in infants, data in older adults remain limited in some countries, including those in Southeast Asia (SEA) and the Middle East and North Africa (MENA) region. Here, we outline the key challenges for understanding the burden of RSV in older adults in SEA and the MENA region and we propose opportunities for improving understanding and eventually reducing the impact of RSV. Main Findings and Conclusions: A key challenge identified by the expert group, particularly in older adults, is a lack of awareness (among healthcare professionals, policy makers, and the public) of RSV burden and the associated risks for severe outcomes. This is often confounded by the complexities of underdiagnosis, surveillance limitations, and comorbidities. To address these issues, we suggest medical education initiatives for physicians in SEA and the MENA region to better understand the need to protect older adults from RSV, and encourage more widespread routine testing to better understand the burden of RSV. We also recommend surveillance studies in these regions to provide comprehensive and accurate epidemiological data on RSV in older adults. Finally, in the absence of current surveillance data in these regions, we propose extrapolating existing global data and local pediatric data to inform the likely burden of RSV in older adults. A graphical abstract is available with this article. Graphical Abstract: (Figure presented.)
dc.identifier.citationAdvances in Therapy (2024)
dc.identifier.doi10.1007/s12325-024-02954-2
dc.identifier.eissn18658652
dc.identifier.issn0741238X
dc.identifier.scopus2-s2.0-85204609541
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/101402
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleKey Challenges to Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Southeast Asia, the Middle East, and North Africa: An Expert Perspective
dc.typeReview
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85204609541&origin=inward
oaire.citation.titleAdvances in Therapy
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationUniversity of Health Sciences
oairecerif.author.affiliationCollege of Medicine and Health Sciences United Arab Emirates University
oairecerif.author.affiliationZayed Military Hospital
oairecerif.author.affiliationAl-Amiri Hospital
oairecerif.author.affiliationKuwait University
oairecerif.author.affiliationGlaxoSmithKline plc.
oairecerif.author.affiliationKing Faisal Specialist Hospital & Research Centre
oairecerif.author.affiliationFaculty of Medicine and Pharmacy of Casablanca
oairecerif.author.affiliationGSK
oairecerif.author.affiliationUniversity of the East College of Medicine
oairecerif.author.affiliationGSK

Files

Collections